Vermillion & White Wealth Management Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17
Closed -$5.56K 90
2025
Q4
$5.56K Hold
17
﹤0.01% 391
2025
Q3
$4.8K Hold
17
﹤0.01% 424
2025
Q2
$4.75K Hold
17
﹤0.01% 375
2025
Q1
$5.3K Hold
17
﹤0.01% 348
2024
Q4
$4.43K Hold
17
﹤0.01% 286
2024
Q3
$5.48K Hold
17
﹤0.01% 255
2024
Q2
$5.31K Hold
17
﹤0.01% 261
2024
Q1
$4.83K Hold
17
﹤0.01% 252
2023
Q4
$4.9K Buy
+17
New +$4.63K ﹤0.01% 209

Other funds holding AMGN

Vermillion & White Wealth Management Group's AMGN Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Amgen (AMGN) in Q1 2026, closing a stake of 17 shares — an estimated $5.56K sold.

Vermillion & White Wealth Management Group first reported a position in AMGN in Q4 2023 and held it in 9 quarters. The position peaked at $5.56K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 17 Amgen shares in Q1 2026, an estimated $5.56K.
  • Vermillion & White Wealth Management Group first reported a position in Amgen in Q4 2023 and held it in 9 quarters.
  • Vermillion & White Wealth Management Group's Amgen position peaked at $5.56K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.